Key facts
- It has raised $67.9M; the latest was Accelerator/Incubator in Jun 2025.
- Notable investors include MedTech Innovator, INNVIERTE SICC, Kurma Partners, Andera Partners, Caixa Capital Risc — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for MedLumics
- ·The full record, as it builds
Funding rounds
No funding rounds for MedLumics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MedLumics
Manufacturer of a radio frequency cardiac ablation system intended to offer treatment of supraventricular tachycardias. The company's system provides real-time, direct visual, confirmation of catheter contact, and contact stability during tissue ablation, enabling doctors to access reduced recurrence rates and procedure technical complexity while increasing procedural safety.
- Sector
- Healthcare
- HQ
- Madrid, Spain
- Founded
- 2009
- Employees
- 27
- Website
- medlumics.com/
- Ownership
- Privately Held (backing)
MedLumics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MedLumics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MedLumics in its N-PORT filings yet. We sweep new filings monthly.